R&D Views & Analysis | pharmaphorum

Views & Analysis

3 key trends shaping the immunology market

From an increase in sales of interleukin inhibitors to the prevalence of biosimilars, this decade has been an eventful one in the immunology industry.

Views & Analysis

Bridging the gap between global trials and regional processe...

Regional differences in processes and regulations are compounding the challenges of 21st century clinical trial management.

Views & Analysis

Has pharma been too slow to respond to coronavirus?

The new coronavirus strain emerging in China is making headlines across the world, with the disease sending entire cities into lockdown in a bid to control its spread.

Views & Analysis

"Fake news" and credibility in medical publishing

Natalie Yeadon looks at how the industry can help healthcare professionals, patients, and their families combat false and misleading scientific information.

Views & Analysis

Antibody-drug conjugates on the march

One of AstraZeneca’s most decisive moves last year came in March, when it signed a multi-billion dollar deal with Japan’s Daiichi Sankyo, focused on just one breast cancer drug.

Views & Analysis

Information hubs and the beginning of a data-driven future

Will 2020 be the year the UK harnesses the potential of its health data, as seven new national ‘data hubs' start to break down data silos and embrace real world evidence?

3 key trends shaping the immunology market

Bridging the gap between global trials and regional processe...

Has pharma been too slow to respond to coronavirus?

"Fake news" and credibility in medical publishing

Antibody-drug conjugates on the march

Information hubs and the beginning of a data-driven future

NHS study will pick apart mental illness with data science

How to meet your physicians where they are online

Views & Analysis

Editor's Picks